Symptom Management in Pancreatic Cancer.


Journal

Current treatment options in oncology
ISSN: 1534-6277
Titre abrégé: Curr Treat Options Oncol
Pays: United States
ID NLM: 100900946

Informations de publication

Date de publication:
02 01 2021
Historique:
accepted: 11 11 2020
entrez: 2 1 2021
pubmed: 3 1 2021
medline: 17 12 2021
Statut: epublish

Résumé

Despite extensive research that has identified new risk factors, genetic mutations, and therapeutic options, pancreatic ductal adenocarcinoma continues to be a leading cause of cancer related death. Patients with pancreatic cancer, along with their clinicians, must balance realistic hope alongside a life-threatening diagnosis. As the search for treatments to reduce the morbidity and mortality continues, symptom management and quality of life remain the focus of our efforts. In addition to side effects of cancer-directed therapy, patients are at risk for malnutrition, pain, and fatigue. These factors are often overlooked in practice, so a multidisciplinary team is critical in optimizing the care of patients.

Identifiants

pubmed: 33387071
doi: 10.1007/s11864-020-00801-4
pii: 10.1007/s11864-020-00801-4
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

8

Auteurs

Kristina G Lee (KG)

Department of Hematology/Oncology, Cedars-Sinai Medical Center, 8700 Beverly Blvd., Suite AC 1042C, Los Angeles, CA, 90048, USA.
Department of Hematology/Oncology, UCLA-Olive View Medical Center, Los Angeles, CA, USA.

Varun Roy (V)

Department of Internal Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Meghan Laszlo (M)

Department of Hematology/Oncology, Cedars-Sinai Medical Center, 8700 Beverly Blvd., Suite AC 1042C, Los Angeles, CA, 90048, USA.

Katelyn M Atkins (KM)

Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Katrina J Lin (KJ)

Department of Supportive Care Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Shant Tomassian (S)

Department of Hematology/Oncology, Cedars-Sinai Medical Center, 8700 Beverly Blvd., Suite AC 1042C, Los Angeles, CA, 90048, USA.

Andrew E Hendifar (AE)

Department of Hematology/Oncology, Cedars-Sinai Medical Center, 8700 Beverly Blvd., Suite AC 1042C, Los Angeles, CA, 90048, USA. Andrew.Hendifar@cshs.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH